(PDN) is the most common complication of both type 1 and 2 diabetes and occurs in more than half of affected individuals in both hospital and clinic settings.
According to DelveInsight s estimates, the total prevalent cases of selected indications for Chronic Pain associated with Painful Diabetic Neuropathy were
7,670,318 cases in the 7MM in
2018 and are expected to get increased by
2030. The 3,782,136 cases in the same year.
Looking forward to the
Medical device technology market for PDN, two technologies are available in the Chronic Pain associated with Painful Diabetic Neuropathy market approved over the years by the
FDA and
EMA.
Transcutaneous electrical stimulation (TENS) is one low-cost option that patients can administer at home and used as a Diabetic Peripheral Neuropathy treatment.
Chronic Pain associated with Painful Diabetic Neuropathy Market Expected to Rise by a CAGR of 15 18% by 2026, Estimates DelveInsight
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Chronic Pain associated with Painful Diabetic Neuropathy Market Expected to Rise by a CAGR of 15 18% by 2026, Estimates DelveInsight
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Among all the Chronic Pain emerging therapies,
Rexlemestrocel (Gruenthal and Mesoblast) is expected to occupy the maximum share of the Chronic Pain market owing to promising efficacy signals shown in the phase II trial and also expected premium pricing.
Interested in knowing more about the report highlights? Get in touch @
Chronic pain is pain, which lasts for more than three months. The pain worsens with time and recurs at undefined periods of time. In normal cases, after healing pain subsidizes; however, in the case of Chronic Pain, the pain persists even after months of treating the root cause.
Chronic Pain may last up to 6 months or even longer, depending on the cause of the injury. The most common causes of Chronic Pain include lower back pain (LBP), arthritis pain, headache and neuropathic pain.
Chronic Pain Market Size Expected to Demonstrate Optimal Growth at a CAGR of 3 0% in the 7MM During the Study Period 2018-2030, Analysis by DelveInsight
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.